We found that apelin infusion increases tyrosine phosphorylation of the key angiogenic marker vascular endothelial growth factor receptor 1 (VEGFR1) (Figure 2I), thereby suggesting an increased tumour neoangiogenesis. The gene discussed is FLT1; the disease is neoplasm.